相关实验视频

Updated: Jan 11, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

长期的新辅助激素治疗可以增强前列腺癌中IL-17A/STAT3介导的炎症

Yirui Wei¹, Yifan Chu², Siqi Wang¹

¹Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, 8 Gongtinanlu, Chaoyang District, Beijing, 100020, China.

Discover oncology

|November 14, 2025

概括

新辅助性激素治疗 (NHT) 通过增强17A (IL-17A) 途径增加前列腺癌 (PCa) 的炎症. 这可能通过STAT3激活促进瘤生长,表明潜在的治疗点.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

前列腺癌 (PCa) 治疗通常涉及新辅助激素疗法 (NHT).
在NHT后的PCa进展中,炎症和特定的信号通路 (例如IL-17A) 在PCa进展中的作用尚未完全理解.
抗雄激素剥夺疗法是先进PCa管理的基石.

研究的目的:

研究NHT对IL-17A信号传递和PCa.炎症的影响.
为了探索IL-17 A/信号转换器和转录3 (STAT3) 轴的激活器在PCa进展后的雄激素剥夺.

主要方法:

分析了27名接受NHT的患者的前列腺组织样本.
使用血素-氨酸染色对组织学炎症的评估.
对IL-17A,IL-17RA,IL-17RC,STAT3和雄激素受体 (AR) 表达的免疫组织化学评估.

主要成果:

在PCa组织中,NHT显著增加了慢性炎症.
瘤组织中IL-17A和IL-17RC的表达率升高,NHT后进一步升高.
IL-17 一种与STAT3正相关的表达,但不是AR.

结论:

长时间的NHT增强了PCa中的IL-17A/IL-17RC介导的炎症,可能通过STAT3激活驱动瘤进展.
针对IL-17A/STAT3轴为高级PCa提供了一个潜在的治疗策略.
在将这些发现纳入临床指南之前,需要进一步验证.

关键词:

它们的IL-17A是IL-17A.炎症炎症是一种炎症.新辅助性激素疗法是一种新辅助性激素疗法.前列腺癌是什么意思前列腺癌是什么意思在STAT3中,我们可以使用STAT3.

更多相关视频

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...